0001415889-15-002006.txt : 20150608
0001415889-15-002006.hdr.sgml : 20150608
20150608164636
ACCESSION NUMBER: 0001415889-15-002006
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150608
DATE AS OF CHANGE: 20150608
EFFECTIVENESS DATE: 20150608
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: FLUOROPHARMA MEDICAL, INC.
CENTRAL INDEX KEY: 0001402785
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 208325616
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-241309
FILM NUMBER: 15918858
BUSINESS ADDRESS:
STREET 1: 8 HILLSIDE AVENUE
STREET 2: SUITE 207
CITY: MONTCLAIR
STATE: NJ
ZIP: 07042
BUSINESS PHONE: 973-744-1565
MAIL ADDRESS:
STREET 1: 8 HILLSIDE AVENUE
STREET 2: SUITE 207
CITY: MONTCLAIR
STATE: NJ
ZIP: 07042
FORMER COMPANY:
FORMER CONFORMED NAME: Commercial E-Waste Management Inc
DATE OF NAME CHANGE: 20070612
D
1
primary_doc.xml
X0707
D
LIVE
0001402785
FLUOROPHARMA MEDICAL, INC.
8 Hillside Avenue
Suite 108
Montclair
NJ
NEW JERSEY
07042
973-744-1565
NEVADA
None
Commercial E-Waste Management Inc
Corporation
true
Johan (Thijs)
M.
Spoor
c/o FluoroPharma Medical, Inc.
8 Hillside Avenue Suite 108
Montclair
NJ
NEW JERSEY
07042
Executive Officer
Director
Tamara
M.
Rhein
c/o FluoroPharma Medical, Inc.
8 Hillside Avenue Suite108
Montclair
NJ
NEW JERSEY
07042
Executive Officer
Walter
M.
Witoshkin
c/o FluoroPharma Medical, Inc.
8 Hillside Avenue Suite 108
Montclair
NJ
NEW JERSEY
07042
Director
Peter
S.
Conti
c/o FluoroPharma Medical, Inc.
8 Hillside Avenue Suite 108
Montclair
NJ
NEW JERSEY
07042
Director
Lawrence
M.
Atinsky
c/o FluoroPharma Medical, Inc.
8 Hillside Avenue Suite 108
Montclair
NJ
NEW JERSEY
07042
Director
Joseph
A.
Pierro
c/o FluoroPharma Medical, Inc.
8 Hillside Avenue Suite 108
Montclair
NJ
NEW JERSEY
07042
Director
Andrew
H.
Sassine
c/o FluoroPharma Medical, Inc.
8 Hillside Avenue Suite 108
Montclair
NJ
NEW JERSEY
07042
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2015-05-28
false
true
true
true
false
0
Merriman Capital, Inc.
18296
Highline Research Advisors LLC
None
711 Fifth Avenue
16th Floor
New York
NY
NEW YORK
10022
CO
COLORADO
NJ
NEW JERSEY
PR
PUERTO RICO
2000000
350000
1650000
false
0
3
28000
0
0
FluoroPharma Medical, Inc.
/s/ Johan M. (Thijs) Spoor
Johan M. (Thijs) Spoor
CEO
2015-06-08